Clinical trial
A Phase 1, Open-Label Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
NCT07559474 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1, Open-Label Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
- Lead sponsor
- Incyte Corporation
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- May 27, 2026
- Completion date
- April 13, 2027
- Enrollment
- 16 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.